These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7448324)

  • 1. Delayed cutaneous hypersensitivity testing in untreated Hodgkin's disease using a standardized new device.
    Lang JM; Giron C; de Leon J; Oberling F
    Biomedicine; 1980 May; 33(3):62-4. PubMed ID: 7448324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Eltringham JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 5. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
    Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
    Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A.
    Kniker WT; Anderson CT; McBryde JL; Roumiantzeff M; Lesourd B
    Ann Allergy; 1984 Feb; 52(2):75-82. PubMed ID: 6696298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
    Gaines JD; Gilmer MA; Remington JS
    Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
    [No Abstract]   [Full Text] [Related]  

  • 9. The multi-test system: a standardized approach to evaluation of delayed hypersensitivity and cell-mediated immunity.
    Kniker WT; Anderson CT; Roumiantzeff M
    Ann Allergy; 1979 Aug; 43(2):73-9. PubMed ID: 380415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin reactivity to bacterial antigens in Hodgkin's disease.
    Rasiewicz W; Kardaszewicz E
    Pol Med J; 1969; 8(5):1203-8. PubMed ID: 5383935
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cutaneous delayed hypersensitivity in a French reference population using the cell-mediated immunity multitest device].
    Biron G; Roumiantzeff M; Ajjan N; Richard C; Tixier G; Serrou B
    Ann Anesthesiol Fr; 1981; 22(3):270-8. PubMed ID: 6117233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hypersensitivity responses of cancer patients to recall antigens using a new "Multitest" applicator.
    Reuben JM; Hersh EM
    Ann Allergy; 1984 Nov; 53(5):390-4. PubMed ID: 6594072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delayed sensitivity in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Grifoni V
    Haematologica; 1972; 57(9):524-8. PubMed ID: 4199305
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
    Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed hypersensitivity in untreated patients with Hodgkin's disease--with special reference to small lymphocyte counts in the blood.
    Tanaka M
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):61-72. PubMed ID: 989232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Association of segmental enteritis and hodgkin's disease with predominantly abdominal localization].
    Bombardieri G; Rossi L; De Rosa G
    Minerva Med; 1972 Jan; 63(3):171-5. PubMed ID: 5058289
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Anergy in Hodgkin's disease.
    Ironside P
    N Engl J Med; 1974 Mar; 290(12):691-2. PubMed ID: 4813734
    [No Abstract]   [Full Text] [Related]  

  • 19. Duration of streptokinase-streptodornase (SK/SD) protency for delayed hypersensitivity skin testing.
    Bretza J; Novey HS
    Ann Allergy; 1980 Oct; 45(4):220-3. PubMed ID: 7425392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tuberculosis in the course of Hodgkin's disease].
    Leménager J; Tanguy A; Bérnard Y
    Cah Med; 1972 Apr; 13(5):357-62. PubMed ID: 5055112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.